Tag: AGH

TGA cannabis changes pot stocks Therapeutic Goods Administration cannabidiol CBD over-the-counter OTC

Drawbacks of the TGA’s cannabis changes for listed pot stocks

Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that ...
Althea ASX AGH online sales medicinal cannabis products concierge

Althea begins online medicinal cannabis sales supported by telemedicine

Two weeks since securing a new patient referral agreement and approvals for more clinic locations, medicinal cannabis company Althea Group (ASX: AGH) has turned its attentions to making commercial pro...
Althea MyAccess Clinics UK expansion Drug Science ASX AGH

Althea’s MyAccess Clinics boosts UK expansion, teams up with Drug Science

Pharma company Althea Group (ASX: AGH) has unveiled a string of advances in the UK citing “significant progress” in securing a new patient referral agreement, further approvals for more clinic locatio...
Althea Group Germany medicinal cannabis sales supply distribution agreement ASX AGH

Althea gets set for German market expansion after executing supply agreement with Nimbus Health

Pharmaceutical company Althea Group (ASX: AGH) has added Germany to its list of active markets following the signing of a three-year supply and distribution agreement with wholesaler Nimbus Health. ...
Althea Group record revenues medicinal cannabis sales ASX AGH patients

Althea Group bags record revenues as medicinal cannabis sales continue growing worldwide

Pharmaceutical company Althea Group (ASX: AGH) has published an interim update regarding its active businesses in Australia, Canada and the UK, declaring that February bettered January as the company’...
Althea Group ASX AGH medicinal cannabis industry Europe concierge Nimbus Health MyAccess Clinics

Althea continues medicinal cannabis industry expansion mission in Europe

Althea Group (ASX: AGH) continues to make inroads into the European market with operations in both the UK and Germany now online, supported by its proprietary technology platform Althea Concierge. ...
Althea Group ASX AGH MMJ first UK prescription Australian manufacturing facility

Althea continues global growth spurt with first UK prescription and green light for Australian manufacturing facility

Medicinal cannabis company Althea Group (ASX: AGH) has found UK market traction after its British subsidiary, Althea MMJ UK, received the first patient prescription for its proprietary medicinal canna...
Althea Group Holdings ASX AGH hemp cultivation licence Tissue Culture Australia

Althea receives green-light to cultivate hemp, teams up with Tissue Culture Australia

Agriculture Victoria has given Althea Group Holdings (ASX: AGH) the green light to cultivate hemp in the state, while Tissue Culture Australia has agreed to assist Althea in developing tissue cultures...
Althea Group ASX AGH local market presence medicinal cannabis distributer Cannvalate

Althea grows local market presence after teaming up with medicinal cannabis distributer

Medicinal cannabis company Althea Group (ASX: AGH) has inked a product supply and distribution agreement with Cannvalate which is expected to underpin further rapid sales growth in Australia. Accor...
Althea ASX AGH medicinal cannabis United Kingdom Aphira patients

Althea expands its medicinal cannabis offering into the UK

Althea (ASX: AGH) is set to become one of the first medicinal cannabis companies to enter the United Kingdom after announcing the acquisition of subsidiary Althea UK. The purchase, of which the val...
Althea Group ASX AGH cannabis export licence

Althea Group bags medical cannabis export licence

Medicinal cannabis company Althea Group (ASX: AGH) has bagged its second licence in as many weeks after securing an export licence from the Australian Government’s Office of Drug Control (ODC). The...
Althea ASX AGH manufacture licence medicinal cannabis

Althea secures manufacturing licence and eyes medical cannabis production

Medicinal cannabis company Althea Group (ASX: AGH) has taken a significant step towards commencing work on its production facility and generating a commercial return from the emergent cannabis industr...
Althea ASX AGH medicinal cannabis patient milestone

Althea hits 100 patient milestone less than a month since listing on the ASX

Less than a month since listing on the ASX, medicinal cannabis company Althea Group (ASX: AGH) has reported that its products are now in the hands of 100 patients, following the launch of five product...
Althea ASX AGH IPO medicinal cannabis

Althea joins the ASX as Australia’s latest medicinal cannabis company

Australian company Althea Group (ASX: AGH) is set to commence trading today after raising $19.6 million at an issue price of $0.20 per share in a heavily oversubscribed IPO. Current CEO and managin...